Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Klin Onkol ; 25 Suppl: S18-20, 2012.
Artigo em Tcheco | MEDLINE | ID: mdl-22920201

RESUMO

Birt-Hogg-Dubé syndrome (BHDS, MIM 135150) is an autosomal dominant condition characterized by presence of skin fibrofolliculomas, lung cysts, spontaneous pneumothorax and renal cancer. The disease is caused by germ-line mutations of the FLCN gene, which encodes protein folliculin. BHDS is a rare condition with high penetrance and variable expression. Clinical recommendations include increased care during general anesthesia due to a higher risk of pneumothorax, and long-term follow-up due to an elevated risk of renal cancer. Diagnostic and predictive DNA tests are available; prenatal and preimplantation diagnosis is possible.


Assuntos
Síndrome de Birt-Hogg-Dubé/genética , Síndrome de Birt-Hogg-Dubé/diagnóstico , Mutação em Linhagem Germinativa , Humanos , Proteínas Proto-Oncogênicas/genética , Proteínas Supressoras de Tumor/genética
3.
Klin Onkol ; 25 Suppl: S16-7, 2012.
Artigo em Eslovaco | MEDLINE | ID: mdl-22920200

RESUMO

Juvenile polyposis syndrome (JPS) is an autosomal dominant disorder characterized by the occurrence of juvenile polyps and predisposition to cancer of the gastrointestinal tract (GIT). Characteristic feature of juvenile polyps are irregular cystic glands filled with mucus not observed in other colorectal cancer syndromes. Germline mutations in the SMAD4 and BMPR1A genes are found in 40% of the JP individuals. Hereditary hemorrhagic telangiectasia (HHT) and higher frequency of gastric polyposis are associated mostly with SMAD4 mutations.


Assuntos
Polipose Intestinal/congênito , Receptores de Proteínas Morfogenéticas Ósseas Tipo I/genética , Humanos , Polipose Intestinal/diagnóstico , Polipose Intestinal/genética , Síndromes Neoplásicas Hereditárias , Proteína Smad4/genética
4.
Klin Onkol ; 25 Suppl: S27-9, 2012.
Artigo em Eslovaco | MEDLINE | ID: mdl-22920203

RESUMO

Rhabdoid tumors (RT) are rare highly malignant tumors. They are part of the embryonic types of tumors and therefore occur in early childhood (between ages of 0-2 years). The most common locations are brain and kidney, but RTs arising usually from soft tissues have been reported widely at most anatomical sites in the body. These tumors are composed of rhabdoid cells alone or as a mixture with primitive neuroectodermal cells, mesenchymal cells and/or epithelial cells, commonly denoted as atypical teratoid/rhabdoid tumours (AT/RT). Based on extremely rare incidence and usually non-specific histological picture, molecular genetic studies are extremely helpful in confirming diagnosis of RT. Biallelic inactivation mutation of the SMARCB1 gene plays a crucial role in the pathogenesis of most RT. One third of mutations are germline mutations leading to the designation of the so-called rhabdoid predisposition syndrome. Molecular genetic analysis of the SMARCB1 gene might be beneficial in the establishment of correct diagnosis, genetic counselling and for epidemiologic studies.


Assuntos
Tumor Rabdoide , Proteínas Cromossômicas não Histona/genética , Proteínas de Ligação a DNA/genética , Predisposição Genética para Doença , Humanos , Tumor Rabdoide/diagnóstico , Tumor Rabdoide/genética , Tumor Rabdoide/patologia , Proteína SMARCB1 , Fatores de Transcrição/genética
5.
Klin Onkol ; 25 Suppl: S30-3, 2012.
Artigo em Tcheco | MEDLINE | ID: mdl-22920204

RESUMO

Hereditary diffuse gastric cancer is an autosomal dominant syndrome with a high lifetime risk of diffuse gastric cancer and also a high risk of lobular breast carcinoma. Hereditary diffuse gastric cancer (HDGC) is characterized by late presentation and a poor prognosis. The average age of onset of HDGC is 38 years, with a range of 14-69 years. The estimated lifetime risk of developing gastric cancer by age 80 is 67% for men and 83% for women. Many families with HDGC have germline mutations in the E-cadherin (CDH1) gene. We describe indication for genetic testing of germline mutations in CDH1 gene, possibilities of predictive testing, preventive care, prophylactic gastrectomy and preimplantation diagnosis.


Assuntos
Neoplasias Gástricas/genética , Adolescente , Adulto , Antígenos CD , Neoplasias da Mama/genética , Caderinas/genética , Feminino , Mutação em Linhagem Germinativa , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Gástricas/patologia , Neoplasias Gástricas/prevenção & controle , Adulto Jovem
6.
DNA Repair (Amst) ; 11(7): 616-23, 2012 Jul 01.
Artigo em Inglês | MEDLINE | ID: mdl-22608206

RESUMO

Cells with DNA repair defects have increased genomic instability and are more likely to acquire secondary mutations that bring about cellular transformation. We describe the frequency and spectrum of somatic mutations involving several tumor suppressor genes in the rectal carcinoma of a 13-year-old girl harboring biallelic, germline mutations in the DNA mismatch repair gene PMS2. Apart from microsatellite instability, the tumor DNA contained a number of C:G→T:A or G:C→A:T transitions in CpG dinucleotides, which often result through spontaneous deamination of cytosine or 5-methylcytosine. Four DNA glycosylases, UNG2, SMUG1, MBD4 and TDG, are involved in the repair of these deamination events. We identified a heterozygous missense mutation in TDG, which was associated with TDG protein loss in the tumor. The CpGs mutated in this patient's tumor are generally methylated in normal colonic mucosa. Thus, it is highly likely that loss of TDG contributed to the supermutator phenotype and that most of the point mutations were caused by deamination of 5-methylcytosine to thymine, which remained uncorrected owing to the TDG deficiency. This case provides the first in vivo evidence of the key role of TDG in protecting the human genome against the deleterious effects of 5-methylcytosine deamination.


Assuntos
Adenosina Trifosfatases/deficiência , Enzimas Reparadoras do DNA/deficiência , Proteínas de Ligação a DNA/deficiência , Mutação em Linhagem Germinativa , Neoplasias Retais/genética , Timina DNA Glicosilase/genética , Adenosina Trifosfatases/genética , Adolescente , Sequência de Aminoácidos , Enzimas Reparadoras do DNA/genética , Proteínas de Ligação a DNA/genética , Feminino , Heterozigoto , Homozigoto , Humanos , Endonuclease PMS2 de Reparo de Erro de Pareamento , Dados de Sequência Molecular , Fenótipo , Neoplasias Retais/metabolismo , Timina DNA Glicosilase/metabolismo
7.
Klin Onkol ; 23(2): 111-4, 2010.
Artigo em Eslovaco | MEDLINE | ID: mdl-20465090

RESUMO

BACKGROUNDS: Cowden syndrome (CS) is a rare autosomal dominant disorder with an increased risk of breast, thyroid and uterine cancer development. The International Cowden Consortium has defined strict diagnostic criteria for individuals and families suspected of having CS. PATIENTS AND METHODS: We analyzed the genomic DNA of 16 patients by sequencing analysis and MLPA (multiplex ligation-dependent probe amplification) method. RESULTS: We found germline mutations, c.825_840del, resp. c.438delT, in 2 patients. Both patients fulfilled strict diagnostic criteria. The other patients, except one, who did not fulfil the criteria, did not harbour any pathogenic mutation. Patients not fulfilling strict diagnostic criteria were included in the study according to major CS criteria but not pathogenic. CONCLUSION: Our results and information from relevant articles show that strict international criteria are well established and analysis of "CS-like" patients has no significant prognostic meaning.


Assuntos
Mutação em Linhagem Germinativa , Síndrome do Hamartoma Múltiplo/genética , PTEN Fosfo-Hidrolase/genética , Adulto , Feminino , Síndrome do Hamartoma Múltiplo/diagnóstico , Síndrome do Hamartoma Múltiplo/patologia , Humanos , Masculino , Pessoa de Meia-Idade , Técnicas de Amplificação de Ácido Nucleico , Análise de Sequência de DNA
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...